5Hopkin J. Mechanisms of asthma [J]. Medicine, 2003, 31 (12): 41-44.
6Viegi G, Scognamiglio A, Baldacci S, et al. Epidemiology of chronic obstructive pulmonary disease (COPD) [J]. Respiration, 2001, 68 (1) : 4-19.
7Berger WE. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma [J]. Ann Allergy Asthma Immunol, 2003, 90 (6) : 583-591.
8Nelson HS. Long-acting beta-agonists in adult asthma: Evidence that these drugs are safe [J]. Prim Care Respir J, 2006, 15 (5):271-277.
9Pauwels R. Formoterol-where does it fit in the current guidelines [J]. Respir Med, 2001, 95 (Suppl B) : S30-S34.
10Kanniess F, Cameron R, Owen R, et al. Indacaterol, a novel once-daily β2-agonist, demonstrates 24-hour efficacy and is well tolerated in patients with persistent asthma [J]. J Allergy Clin Immunol, 2006, 117 (2): S196-S197.
